Literature DB >> 24811253

Authors' reply to Verdelli et al.: there is no knowledge without experience.

Francesca Ingegnoli1, Athanasia Tourlaki, Roberta Gualtierotti.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24811253     DOI： 10.1007/s40261-014-0201-6

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  3 in total

1.  Is tocilizumab safe in Kaposi sarcoma? A complex association among rheumatoid arthritis, psoriasis, and Kaposi sarcoma.

Authors:  Alice Verdelli; Diletta Bonciani; Veronica Bonciolini; Marzia Caproni
Journal:  Clin Drug Investig       Date:  2014-06       Impact factor: 2.859

2.  The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element.

Authors:  Jiabin An; Alan K Lichtenstein; Gregory Brent; Matthew B Rettig
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

3.  Tocilizumab monotherapy in a patient with rheumatoid arthritis and iatrogenic Kaposi sarcoma.

Authors:  Francesca Ingegnoli; Athanasia Tourlaki; Roberta Gualtierotti
Journal:  Clin Drug Investig       Date:  2014-02       Impact factor: 3.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.